StockData

Dynatrace vs NICE

DT and NICE side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DT and NICE compare

Dynatrace grew revenue faster over the last twelve months (17.8% versus 7.7% for NICE).

NICE keeps more of each dollar of sales as profit, with a net margin of 20.8% compared with 7.4% at Dynatrace.

Dynatrace scores higher on the StockData Score (15 against 13 for NICE), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDTNICE
Size and price
Market cap$12.8B–
Share price$44.24$94.23
Change, 1 year−5.3%−26.4%
Change, 5 years−34.0%−67.7%
Beta (5Y)1.351.22
Employees5,6004,000
StockData Score
Total score15 (better)13
Valuation score2 (better)0
Growth score33
Performance score45 (better)
Health score6 (better)5
Dividend score00
Valuation
P/E81.9×–
P/S5.9×–
P/B5.6×–
EV/EBITDA38.4×–
P/FCF22.1×–
PEG6.10–
FCF yield4.5%–
Fair value$28.61–
Margin of safety−54.6%–
Growth
Revenue growth (TTM)17.8% (better)7.7%
Revenue growth, 5Y average23.5% (better)12.3%
Net income growth (TTM)−68.0%39.3% (better)
EPS growth (TTM)−67.7%43.0% (better)
EPS growth, 5Y average15.7%26.5% (better)
Profitability
Gross margin81.0% (better)66.4%
Operating margin12.7%21.9% (better)
Net margin7.4%20.8% (better)
FCF margin26.5% (better)23.7%
Return on equity6.4%16.4% (better)
Return on invested capital17.5%19.1% (better)
Financial health
Debt / equity0.000.00
Net debt / EBITDA–−0.49
Interest coverage231×–
Current ratio2.09 (better)1.55
Altman Z-score3.62–
Piotroski F-score57 (better)
Dividends and buybacks
Buyback yield7.1%–
Shareholder yield7.1%–
Ownership
Held by institutions105%58.1%
Held by insiders5.6%0.40%
Insider net buying, 12 months−$3.1M−$50.0K (better)
Superinvestors holding1–
Short interest, % of float5.2%–

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.